Ebastine

5 trials 3 recruiting RRespiratory

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

3 Recruiting

2 Completed trials

5 Sponsors

4 Countries

Phase III

Phase II/III

Phase II

Phase IV

Phase III: 2 Phase II/III: 1 Phase II: 1 Phase IV: 1

Sponsors using this IMP

Inmunotek S.L. 2 A. Menarini Industrie Farmaceutiche Riunite S.r.l. 1 Faes Farma S.A. 1 Rigshospitalet 1 UZ Leuven 1

All trials

5 total

A prospective, randomized, double-blind, placebo-controlled, multicentre, dose-finding clinical trial with polymerised mannan-conjugated all… Recruiting

2025-524580-21-00 Phase II/III 1 country Inmunotek S.L.
Ebastine in combination with docetaxel or as a treatment for metastatic castration-resistant prostate cancer Recruiting

2024-518035-11-01 Phase II 1 country Rigshospitalet
Multicenter randomized controlled clinical trial comparing ebastine and mebeverine as treatment of irritable bowel syndrome Recruiting

2022-501780-41-00 Phase III 1 country UZ Leuven
A clinical trial to compare three oral treatments and a placebo in preventing skin reactions caused by histamine in healthy volunteers Ended

2024-516569-35-00 Phase IV 1 country A. Menarini Industrie Farmaceutiche Riunite S.r.l.; Faes Farma S.A.
A prospective, randomized, double-blind placebo-controlled multicentre trial with mannan-conjugated birch pollen allergoids administered sub… Ended

2024-515717-17-00 Phase III 1 country Inmunotek S.L.

Showing 1–5 of 5 trials

← All drugs A–Z